SCAI Shock Stages A Through E The Society for Cardiovascular Angiography and Intervention (SCAI) has classified cardiogenic shock into stages from A through E. This was developed by
MELD and MELD-XI scores Model for End-Stage Liver Disease (MELD) score is a logarithmic function of creatinine, total bilirubin and International Normalized Ratio (INR): MELD = 9.57(logeCreatinine) + 3.78(logeBilirubin) + 11.21(logeINR)
Cardiology MCQ – Least progression of valvular lesion – Answer Which of these three lesions is least likely to progressive and have a favourable clinical course among aortic
Potential mechanisms of reduced heart failure hospitalization with SGLT2 inhibitors Four main potential reasons for protection against heart failure (HF) hospitalization by SGLT2 inhibitors: Contraction of plasma volume
Cardiology MCQ – Least progression of valvular lesion Which of these three lesions is least likely to progressive and have a favourable clinical course among aortic stenosis, mitral
Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy – Answer Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Correct
CHAD-STOP for cardiac amyloidosis CHAD-STOP is the mnemonic for the initial steps in the management of cardiac amyloidosis: C: Conduction and rhythm disorder prevention H: High heart rate
Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Trastuzumab Tafamidis Tranexamic
Risk factors for non response with CRT About one third of patients who receive a cardiac resynchronization therapy (CRT) do not respond well to the device therapy. Some